| Financial Year |
March 31 2023 |
| Monetary Funds |
128,740,233.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,057,941.56 |
| Accounts Receivable |
1,208,242,898.74 |
| Advances to Suppliers |
65,928,126.43 |
| Other Receivables |
25,383,106.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,532,676,683.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,144,817.39 |
| Total Current Assets |
3,114,729,211.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,467,669.45 |
| Investment Properties |
197,682.29 |
| Fixed Assetes |
395,502,975.15 |
| Under-construction Projects |
1,283,695.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,602,730.07 |
| R&D expenses |
-- |
| Goodwill |
58,378,542.14 |
| Long-Term Deferred and Prepaid Expenses |
11,088,353.83 |
| Deferred Income Tax Assets |
98,173,833.62 |
| Other Non-Current Assets |
20,659,941.87 |
| Sub-Total of Non-Current Assets |
788,632,828.88 |
| Total Assets |
3,903,362,040.64 |
| Short-Term Loans |
191,155,638.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,261,030.00 |
| Accounts Payable |
1,594,836,854.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,313,763.99 |
| Taxes Payable |
5,871,272.32 |
| Interest Payable |
665,940.20 |
| Dividend Payable |
-- |
| Other payables |
512,675,136.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,094,410.45 |
| Other Current Liabilities |
51,578,712.93 |
| Sub-Total of Current Liabilities |
3,445,027,677.81 |
| Long-term Loans |
94,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
51,592,711.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
206,603.77 |
| Sub-Total of Non-Current Liabilities |
245,581,307.62 |
| Total Liabilities |
3,690,608,985.43 |
| Paid-In Capital(Or Share Stock) |
213,574,120.00 |
| Capital Surplus |
882,168,975.47 |
| Surplus Reserve |
30,441,145.96 |
| LESS:Treasury Stock |
10,420,326.00 |
| Undistributed Profits |
-886,598,310.12 |
| Minority Stockholder's Interest |
912,849.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
211,840,205.31 |
| Owner's Equity（Stockholder's Equity） |
212,753,055.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,903,362,040.64 |
